To clarify the physiological role of calcium-activated neutral protease (CANP) in human platelets, we loaded the platelets with a Ca 2+ -sensitive fluorescent dye, fura-2, and measured the degree of aggregation, cytosolic calcium ion concentration ([Ca J+ ],), and proteolysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). At physiological concentration of Ca 2+ (1 mM) in the incubation medium, [Ca 2+ ], was below 0.5 fiM and platelet aggregation was not shown. Ionomycin (0.15 /iM) or collagen (50 /xg/ml), but not ADP (10 fiM), sharply enhanced the [Ca 2+ ], to near 1 /*M and caused the aggregation. A calcium entry blocker, verapamil, completely abolished both the [Ca J+ ], rise and the aggregation. NCO-700, a membrane permeable inhibitor against cysteine proteases (including CANP), dosedependently blocked the aggregation but did not change the [Ca 2+ ], transient. SDS-PAGE revealed that filamin, talin, and 70 kDa protein were specifically degraded when platelets were aggregated by ionomycin or collagen and that the proteolysis was not observed when the aggregation was blocked by verapamil or NCO-700. These data provided evidence that Ca 2+ entry exceeding 0.5 /iM is essential, but not sufficient per se, and that activation of cysteine protease, most likely CANP, is involved in the platelet aggregation by collagen or calcium ionophore. (Circulation Research 1989;64:407-410) 
T he exact process of platelet aggregation is still obscure. Several mechanisms, including arachidonic acid release/thromboxane A 2 or phosphatidylinositide/protein kinase C systems, have been described. 1 In any case, calcium entry into cytosol precedes the aggregation. 2 Human platelets, as well as other tissues, include a cysteine protease, calcium-activated neutral protease (CANP), 3 -7 though, excepting myofibrillar protein degradation in pathophysiological conditions, 8 -' 1 physiological function of the enzyme is unclear. Very recently, a cysteine protease inhibitor, NCO-700, was synthesized and found to be inert in living animals, to pass through the cell membrane, and to block proteolysis in living muscle cells. 1213 The present study was undertaken to explore the interaction of platelet aggregation, intracellu-lar calcium ion ([Ca 2+ ],) transient, and degradation of constituent proteins, with NCO-700 as a pharmacological tool.
Materials and Methods

Isolation of Human Platelets and Loading of Fura-2
Venous blood from healthy human volunteers (n=6) was sampled in the presence of sodium citrate (0.8%) and centrifuged at 800g for 10 minutes. Fura-2-AM (Dojin Chemicals, Tokyo) was added to the supernatant to a final concentration of 1 ^.M and incubated at 37° C for 30 minutes. The supernatant was centrifuged at 3,000g for 15 minutes, and the pellet was gently suspended in 5 ml of a solution (A) that contained 150 mM NaCl, 20 mM Tris-Cl buffer (pH 7.4), and 100 mg/dl glucose. The final number of platelets was counted by a Coulter counter and adjusted to 5.Ox lOV/xl with solution A.
Measurement of Platelet Aggregation and Calcium Transient
An aliquot of prepared platelet suspension was incubated in the absence or presence of NCO-700 (10 ^iM to 1 mM in final concentration) for 5 minutes at 37° C, mixed with Ca 2+ (1.0 mM), and then stimulated by collagen (50 /ng/ml), ionomycin (0.15 IxM), or ADP (10 jitM). In all steps, platelet aggregation was monitored with a spectrometer.
With the same sample and the same conditions, [Ca 2+ ] f was assayed with double wavelength excitation (340 and 380 nm) and single emission (502 nm) fluorescent spectrophotometry developed by Tsien's group. 14 At each step, after addition of reagent, excitation wave length was scanned from 300 to 420 nm and recorded on an x-y chart. Control experiment of the same platelets without fura-2 loading was performed, and autofluorescence was subtracted from the total fluorescence curve. For the calculation of free Ca 2+ concentration, a calibration line was constructed with 5 mM Ca 2+ -ethyleneglycol-bisQ3-aminoethylether)-.N,A/,Af',Af'-tetraacetic acid buffer 15 and 10 fiM free acid fura-2.
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Assay of Phospholipase A 2 or C Activity
To examine direct effect of NCO-700 on phospholipase A 2 or phospholipase C, these enzyme activity in isolated human platelets was measured in the absence or presence of NCO-700, following the method of Teramoto et al 16 
Miscellaneous
Before and after the [Ca 2+ ]i measurement, an aliquot was sampled to check proteolysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). 18 Protein bands were visualized with silver staining. 19 Reagents used were of analytical grade, and water was redistilled before use. NCO-700 was donated by Dr. M. Masaki, Nippon Chemiphar, Tokyo.
Results
Aggregometry of Platelets
In the absence or the presence of the physiological concentration of calcium (1 mM) in the incubation medium, platelet aggregation did not take place (Figures 1 and 2 ). Collagen (50 /ug/ml) and ionomycin (0.15 fiM) stimulated the platelet aggregation ( 
Intracellular Ca 2 * Transient in Platelet Aggregation
As summarized in Figure 3 , the basal level of [Ca 2+ ]j before addition of calcium was 80±38 nM (mean±SEM, n=6). Physiological concentration of Ca 2+ (1 mM) in the incubation medium increased the [Ca 2+ ]i fourfold to 350±63 nM. Stimulation by collagen (50 /ig/ml) sharply enhanced the [Ca 2+ ]j to above 0.8 (JM (Figure 3 , unfilled triangles) within 5 minutes. Ionomycin (0.15 /xM) raised the [Ca 2+ ]j even more sharply (unfilled squares).
A calcium entry blocker, verapamil (1 mM), did not interfere with the measurement of [Ca 2+ ]; and blocked the rise of [Ca 2+ ], caused by collagen ( Figure  3 , cross marks), indicating that verapamil surely blocked calcium entry in human platelets. These data demonstrated that the threshold of about 500 nM must be exceeded for platelet aggregation.
The cysteine protease inhibitor NCO-700 (1 mM) had no effect on the rise of [Ca 2+ ]| after the stimulation of collagen (50 fig/ml, filled triangles) or ionomycin (0.15 piM, filled squares). These results indicated that the inhibitory action of NCO-700 did not originate from the calcium entry blocking effect but suggested an involvement beyond the calcium entry step. 
SDS-PAGE of Platelet Proteins Before or After Stimulation
After staining by silver nitrate, isolated human platelets showed more than 30 protein bands ( Figure  4A ). Physiological concentration of Ca 2+ (1 mM) caused a minor extra band at 180 kDa ( Figure 4B) . The origin of the protein was not pursued because this protein band was not directly correlated with the platelet aggregation. When the aggregation was blocked by verapamil, no change was documented between the samples before and after the stimulation by collagen ( Figure  4C ). In contrast, collagen-stimulated platelets revealed a definite density reduction of three protein bands at 250, 235, and 70 kDa ( Figure 4D ). NCO-700 treatment of platelets completely inhibited the proteolysis, and there was no change in the mobility or density of protein bands compared with the sample before the stimulation ( Figure 4E ).
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Effect of NCO-700 on Activity of Phospholipase A 2 or C
To examine the NCO-700 effect on phospholipase A 2 or C, we measured their activities in the absence and presence of the reagent. NCO-700 revealed no definite effect on phospholipase A 2 activity: 24.3 ± 1.4 nmol/2 hrs without NCO-700 and 21.4±0.5 or 22.6±0.5 nmol/2 hrs at 10" 4 M or 10" 3 M NCO-700, respectively. The activity of phospholipase C was not inhibited but rather raised by high concentration of NCO-700: 10.2±1.8 nmol/2 hrs without NCO-700 and 15.6±0.5 (p<0.05) or 12.9±1.8 nmol/2 hrs at 10~4 or 10~3 M NCO-700, respectively.
Discussion
Calcium ionophore, ionomycin, or collagen stimulated Ca 2+ entry, platelet aggregation, and the degradation of 250, 235, and 70 kDa proteins. From the molecular weight and preferential degradation by CANP, we tentatively identified the 250 kDa, 235 kDa, and 70 kDa protein as filamin (actin-binding protein), 20 talin, 21 and glycoprotein Ib, 20 respectively. In contrast, a calcium entry blocker, verapamil, inhibited the [Ca 2+ ]j rise, platelet aggregation, and the hydrolysis of these proteins. These data provided evidence that calcium entry from outside in excess of 0.5 /xM was essential for platelet aggregation. However, it was not sufficient per se to cause the aggregation, and cysteine protease activation was mandatory for the aggregation because NCO-700, an inhibitor against cysteine protease (including CANP), blocked both platelet aggregation and the proteolysis in spite of Ca 2+ entry. Simplified results are summarized in Table 1 22 NCO-700 is a cysteine protease inhibitor like leupeptin or antipain 23 ; it is not specific for CANP but blocks other cysteine proteases such as cathepsin B, H, or L that are included in lysosomes. However, the reagent is more inert to living cells than leupeptin or antipain, as we reported earlier. 1213 It would be reasonable to assume that the protease responsible for platelet aggregation is CANP, because CANP requires Ca 2+ for the activation. 3 -7 Actually, Fox et al demonstrated that CANP isolated from human platelets degraded filamin (250 kDa, actin-binding protein) 20 and talin (235 kDa protein). 2021 These in vitro studies by isolated protease and substrate proteins are in complete agreement with the present results of whole platelets and might provide evidence that CANP among cysteine proteases is activated in platelet aggregation by ionomycin or collagen.
The involvement of the lysosomal proteases cathepsin B, H, or L in platelet aggregation is not likely because these cathepsins are insensitive to Ca 2+ and require acidic pH for their activation. A more complicated mechanism to explain Ca 2+ -triggered proteolysis could be the involvement of phospholipase A 2 or C, which is Ca 2+ -dependent. 24 However, the possibility was excluded because NCO-700 did not inhibit the activity of these phospholipases. To access the pathway of platelet aggregation, identification of the protein responsible for the platelet aggregation is needed in a more elaborate study.
